Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression. (2018)
Attributed to:
Psilocybin as a treatment for major depression
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.neuropharm.2017.12.041
PubMed Identifier: 29288686
Publication URI: http://europepmc.org/abstract/MED/29288686
Type: Journal Article/Review
Volume: 142
Parent Publication: Neuropharmacology
ISSN: 0028-3908